MGRX · NASDAQ
Mangoceuticals (MGRX) Stock Price & Fundamentals
Mangoceuticals (MGRX) closed at $395.79 on Oct 9, 2026, down 0.26% from the previous close of $396.82.
Share price, past year
1Y +34.07%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $395.79 |
| Sep 30, 2026 | $382.36 |
| Aug 31, 2026 | $363.04 |
| Jul 31, 2026 | $389.75 |
| Jun 30, 2026 | $360.42 |
| May 29, 2026 | $351.07 |
| Apr 30, 2026 | $355.37 |
| Mar 31, 2026 | $325.52 |
| Feb 27, 2026 | $310.12 |
| Jan 30, 2026 | $312.25 |
| Dec 31, 2025 | $314.61 |
| Nov 28, 2025 | $289.52 |
| Oct 31, 2025 | $301.78 |
Key statistics
- Market cap
- $7.13B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.79
- Revenue (TTM)
- $315.23K
- Net income (TTM)
- −$15.10M
- Shares outstanding
- 18M
- Dividend yield
- —
- 52-week range
- $285.26 – $396.82
Mangoceuticals's market cap is $7.13B, based on a share price of $395.79 and 18M shares outstanding as of Jun 30, 2026.
Financials
Mangoceuticals reported revenue of $456.02K for fiscal 2025, down 25.96% from fiscal 2024.
Mangoceuticals reported a net loss of $20.64M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $456.02K | −26.0% | −$20.64M | −4,526.8% | −$2.17 | — |
| FY2024ended Dec 31, 2024 | $615.87K | −15.8% | −$8.71M | −1,413.6% | −$4.80 | — |
| FY2023ended Dec 31, 2023 | $731.49K | +8,083.2% | −$9.21M | −1,259.4% | −$8.58 | −$7.00M |
| FY2022ended Dec 31, 2022 | $8.94K | — | −$2.00M | −22,352.1% | −$0.19 | −$1.39M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $68.76K | −$1.31M | −$0.09 |
| Q1 FY2026ended Mar 31, 2026 | $67.86K | −$3.40M | −$0.22 |
| Q4 FY2025ended Dec 31, 2025 | $94.36K | −$2.77M | $0.21 |
| Q3 FY2025ended Sep 30, 2025 | $84.25K | −$7.62M | −$0.69 |
| Q2 FY2025ended Jun 30, 2025 | $168.11K | −$5.42M | −$0.57 |
| Q1 FY2025ended Mar 31, 2025 | $109.31K | −$4.84M | −$1.12 |
| Q4 FY2024ended Dec 31, 2024 | $105.25K | −$1.95M | −$0.79 |
| Q3 FY2024ended Sep 30, 2024 | $133.37K | −$2.00M | −$1.14 |
Company profile
- Name
- Mangoceuticals, Inc.
- Ticker
- MGRX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Misc Health & Allied Services, NEC
- Headquarters
- 15110 Dallas Pkwy, Suite 600, Dallas, TX 75248
- Incorporated in
- TX
- Fiscal year ends
- December
- SEC CIK
- 0001938046
Recent SEC filings
- Oct 1, 2026
- Aug 21, 2026
- Aug 13, 2026
- Aug 4, 2026
- Jul 30, 2026
- Jul 2, 2026
- May 19, 2026
- Apr 1, 2026
Frequently asked questions
What is Mangoceuticals's stock price?
Mangoceuticals (MGRX) closed at $395.79 on Oct 9, 2026, down 0.26% from the previous close of $396.82.
What is Mangoceuticals's market cap?
Mangoceuticals's market cap is $7.13B, based on a share price of $395.79 and 18M shares outstanding as of Jun 30, 2026.
How much revenue does Mangoceuticals make?
Mangoceuticals reported revenue of $456.02K for fiscal 2025, down 25.96% from fiscal 2024.
Does Mangoceuticals pay a dividend?
Mangoceuticals's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Mangoceuticals, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures